Tag Archives: patients

High-dose vitamin D shows benefit in patients with advanced colorectal cancer

Results of a small clinical trial suggest that supplementing chemotherapy with high doses of vitamin D may benefit patients with metastatic colorectal cancer by delaying progression of the disease, say scientists from Harvard-affiliated Dana-Farber Cancer Institute. Prompted by the “very encouraging” results of the Sunshine clinical trial, the potential benefits of vitamin D supplementation in metastatic… Read More »

Artificial intelligence can identify at-risk patients, inform care and improve disease prevention

There’s no shortage of buzz around artificial intelligence and its potential impact on a variety of areas within healthcare, from patient care to revenue cycle operations. There is an emerging trend toward AI assets that amplify the value of patient data and provide an extendable, scalable pathway to effective primary disease prevention. That’s something that… Read More »

FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia

Print this page HORSHAM, Pa., Jan. 28, 2019 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of Imbruvica (ibrutinib) in combination with obinutuzumab in treatment-naïve patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), the most common form of leukemia in adults.1 This is… Read More »